C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/1999
12/02/1999	CA2329072A1 Human transmembrane proteins
12/02/1999	CA2329053A1 Human socs proteins
12/02/1999	CA2328902A1 Novel secreted and membrane-associated proteins and uses therefor
12/02/1999	CA2328892A1 Tumor suppressor
12/02/1999	CA2328451A1 Differential cytotoxicity of alternative forms of rotavirus nonstructural protein 4
12/02/1999	CA2328134A1 The induction of antibiotic proteins and peptides by lait/scd14-protein
12/02/1999	CA2325462A1 Novel nucleic acids and polypeptides related to a farnesyl-directed endopeptidase
12/02/1999	CA2234420A1 Methods for the detection, treatment, and prevention of neurodegeneration
12/01/1999	EP0960941A1 Gene Therapy for cell proliferative diseases
12/01/1999	EP0960939A2 Dual-tagged proteins and their uses
12/01/1999	EP0960936A1 Reconstituted human anti-hm1.24 antibody
12/01/1999	EP0960339A1 Assay for collagen type ii fragments
12/01/1999	EP0960336A1 Peptide reagent for the detection of human cytomegalovirus (cmv)
12/01/1999	EP0960334A1 Vegf-b/receptor complex and uses thereof
12/01/1999	EP0960203A1 Mammalian chk1 effector cell-cycle checkpoint protein kinase materials and methods
12/01/1999	EP0960201A1 Mammalian ribonuclease inhibitors and use thereof
12/01/1999	EP0960199A2 Secreted proteins and polynucleotides encoding them
12/01/1999	EP0960196A1 Novel receptor that causes cell death
12/01/1999	EP0960130A1 Oxygen-binding heme proteins incorporating circularly-permuted globins
12/01/1999	EP0960127A1 Isolated dimeric fibroblast activation protein alpha, and uses thereof
12/01/1999	EP0960120A1 MAMMALIAN SEX COMB ON MIDLEG (MAMMALIAN Scm) ACTS AS AN ONCOGENE
12/01/1999	EP0960117A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
12/01/1999	EP0959907A1 The butyrophilin gene promoter and uses thereof
12/01/1999	EP0959901A1 A method for generating birnavirus from synthetic rna transcripts
12/01/1999	EP0959899A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
12/01/1999	EP0959898A1 Lactoferrin variants and uses thereof
12/01/1999	EP0959895A1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins
12/01/1999	EP0763128B1 Method for producing heterologous bispecific antibodies
12/01/1999	EP0755517B1 A method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein
12/01/1999	CN1237205A Enhanced expression of proteolytic enzymes in koji mold
11/1999
11/30/1999	US5994628 Process for protein production in plants
11/30/1999	US5994616 Targeted synthesis of protein in mammary gland of a non-human transgenic mammal
11/30/1999	US5994527 Fungus-responsive chimeric gene
11/30/1999	US5994524 Polynucleotides which encode reshaped IL-8-specific antibodies and methods to produce the same
11/30/1999	US5994523 A nucleic acid molecule encoding a peptide comprising a sequence consisting of 8 contiguous amino acids of th mart-1(melanoma antigen recognized by t-cell-1) a preferential amino acid sequence which is capable of reacting tumor
11/30/1999	US5994516 Mutated proteins encoded by a lentivirus mutated env gene, peptide fragments and expression vectors
11/30/1999	US5994513 Oncoprotein protein kinase
11/30/1999	US5994511 Anti-IgE antibodies and methods of improving polypeptides
11/30/1999	US5994504 Vitamin D response element binding protein
11/30/1999	US5994503 Nucleotide and protein sequences of lats genes and methods based thereon
11/30/1999	US5994307 Human t-cell lymphoma virus
11/30/1999	US5994304 Polypeptide
11/30/1999	US5994301 Corpuscles of stannius protein, stanniocalcin
11/30/1999	US5994300 Vascular endothelial cell growth factor C subunit
11/30/1999	US5994125 A synthetic oligonucleotide; anticoagulant, hypertensive agent, antiinflammatory agent,
11/30/1999	US5994119 Mammalian regulator of nonsense-mediated RNA decay
11/30/1999	US5994116 Preparing a non-infectious viral particle having defects in its replication proteins; infecting cells with the virus and a chemical inhibitor of dna synthesis, preventing viral replication and recovering the desired particles; vaccines
11/30/1999	US5994114 A polynucleotide which codes for a protein having taxadiene synthase activity; chemotherapy
11/30/1999	US5994112 A polynucleotide which codes a protein; antiproliferative agents, anticarcinogenic agents, antiinflammatory agents
11/30/1999	US5994111 A polypeptide; treatment and diagnosis of respiratory infections, septic arthritis, cardiovascular infections, gastrointestinal infections, toxic shock syndrome; antibiotics
11/30/1999	US5994100 HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia
11/30/1999	US5994098 G protein coupled receptor gene; treatment of pain, diabetes, eating disorders, asthma; hypotensive/hypertensive agents; parkinson's/huntington's/cardiovascular diseases, ulcers, anticarcinogenic/antiallergens agents; osteoprosis,
11/30/1999	US5994096 Regulator
11/30/1999	US5994095 MTS2 gene
11/30/1999	US5994094 A bone morphogenetic protein; treatment of osteoporosis, prevent transplant rejection; wound healing agents; regeneration of bones, cartilage, connective tissue, skin, mucous membranes, epithelium and teeth
11/30/1999	US5994090 Using a phosphocholine-containing glycoglycerophospholipid from a mycoplasma as an immunogen to obtain an antibody specific to the glycoglycerophospholipid; aids therapy
11/30/1999	US5994088 Treating cells with a glycoprotein substrate from a group; reserpine, gramicidin, cyclosporine, vincristine, actinomycin d, taxol, verapamil and vinblastine; reacting cells with antibody to glycoprotein/substrate, detect increase binding
11/30/1999	US5994084 A cell that enodgenously expresses the protein tau and having a gene encoding a kinase that modulates phosphorylation of the protein tau; cultured cell exhibited hyperphosphorylation of tau and neurofibrillary tangles; preventing alzheimer's
11/30/1999	US5994060 Gro genes, proteins, and uses thereof
11/30/1999	US5994054 Creating an expression library, transfecting cells with a dna molecule which contains a long terminal repeat promoter sequence of human immunodeficiency virus adjacent to a reporter molecule, measuring viricide activity
11/30/1999	US5993828 Administering to the subject an effective dose of a composition comprising inactivated tumor cells having urinary tumor associated antigen on the cell surface and at least one tumor associated antigen
11/30/1999	US5993827 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins
11/30/1999	US5993826 Relates generally to various outer membrane proteins (omps) of moraxella catarrhalis for use as targets in immunotherapy
11/30/1999	US5993825 Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
11/30/1999	US5993818 Use of autoantibodies for tumor therapy and prophylaxis
11/30/1999	US5993816 Methods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodies
11/30/1999	US5993813 Family of high affinity, modified antibodies for cancer treatment
11/30/1999	CA2128250C Insecticidally effective peptides
11/30/1999	CA2024607C Recombinant dna method and host cells
11/30/1999	CA1340835C Expression vectors and methods for intracellular protein production
11/30/1999	CA1340834C Derivatives of human/bovine basic fibroblast growth factor
11/30/1999	CA1340833C Activated killer monocytes: tumoricidal activity and method of monitoring same
11/30/1999	CA1340832C Recombinant cmv neutralizing proteins
11/30/1999	CA1340830C Process for production of physiologically active peptide containing cysteine residue
11/25/1999	WO1999060171A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products
11/25/1999	WO1999060153A2 Novel g-protein coupled receptor
11/25/1999	WO1999060152A1 Process for sialylating glycoproteins
11/25/1999	WO1999060150A1 Method for catalysing complex reactions of large molecules using enzymes which are bonded to a polymer support
11/25/1999	WO1999060139A1 ENZYMATICALLY-ACTIVE RECOMBINANT HUMAN β-TRYPTASE AND METHOD OF MAKING SAME
11/25/1999	WO1999060137A2 Methods for producing heterologous polypeptides in trichothecene-deficient filamentous fungal mutant cells
11/25/1999	WO1999060136A1 Methods for producing polypeptides in filamentous fungal mutant cells
11/25/1999	WO1999060135A1 Generation of multiple gene products from chimeric fusion proteins by cleavage with ubiquitous endoproteases
11/25/1999	WO1999060134A1 New peptide fragments for protein purification
11/25/1999	WO1999060132A1 Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
11/25/1999	WO1999060131A2 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof
11/25/1999	WO1999060127A2 Il-17 homologous polypeptides and therapeutic uses thereof
11/25/1999	WO1999060120A2 Soluble t cell receptor
11/25/1999	WO1999060119A2 Multivalent t cell receptor complexes
11/25/1999	WO1999060112A1 Antibodies and utilization thereof
11/25/1999	WO1999060099A1 Amino acid modified polypeptides
11/25/1999	WO1999060025A1 Gene recombinant antibodies
11/25/1999	WO1999060024A1 Methods for amyloid removal using anti-amyloid antibodies
11/25/1999	WO1999060023A1 Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases
11/25/1999	WO1999060020A1 Secreted proteins and polynucleotides encoding them
11/25/1999	WO1999060019A1 HUMAN EDG3sb GENE
11/25/1999	WO1999060017A2 Human tumour-derived polypeptide hormone phosphatonin
11/25/1999	WO1999059633A1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody
11/25/1999	WO1999059629A1 Humanized antibodies that recognize verotoxin ii and cell line producing same
11/25/1999	WO1999059619A1 Acrp30r1: a homolog of acrp30 (30 kd adipocyte complement-related protein)
11/25/1999	WO1999059618A1 Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein)

1 ... 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 ... 1125